EUVIMEDEUVIMED entdecken
Crossref

Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer

Song Mi, Yunxin Yang, Xin Liu, Shaotong Tang, Ning Liang, Jinyue Sun, Chao Liu, Qidong Ren, Jihong Lu, Pingping Hu, Jiandong Zhang

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03471-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Song Mi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shandong University of Traditional Chinese Medicine, Shandong Provincial Qianfoshan Hospital, Jinan, China. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Lung Neoplasms, Small Cell Lung Carcinoma, Progression-Free Survival. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Shandong Natural Science Foundation, National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsLung NeoplasmsSmall Cell Lung CarcinomaProgression-Free SurvivalHumansRetrospective StudiesMaleFemaleAgedMiddle AgedPrognosisTime FactorsNeoplasm StagingAntineoplastic Combined Chemotherapy ProtocolsAged, 80 and overAdultSurvival Rate

Stichwörter der Autor:innen

Extensive-stage small-cell lung cancer (ES-SCLC)ImmunotherapyLines of treatmentPrognostication

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Oncology, Shandong University of Traditional Chinese Medicine, Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lun…
  • Department of Oncology, Shandong Provincial Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • School of Clinical Medicine, Weifang Medical University, Weifang, China.
  • Key Laboratory of Novel Food Resources Processing, Ministry of Agriculture and Rural Affairs/Key Laboratory of Agro-Products Processing Technology of Shandong Province/Institute of Agro-Food Science and Technology, Shan…
  • College of Clinical and Basic Medicine of Shandong First Medical University, Jinan, China.

Förderung

  • Shandong Natural Science Foundation
  • National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers

Zitieren

APA

Mi, S., Yang, Y., Liu, X., Tang, S., Liang, N., Sun, J., Liu, C., Ren, Q., Lu, J., Hu, P., & Zhang, J. (2024). Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03471-y

Vancouver

Mi S, Yang Y, Liu X, Tang S, Liang N, Sun J, et al. Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03471-y

BibTeX
@article{Mi2024,
  author = {Mi, Song and Yang, Yunxin and Liu, Xin and Tang, Shaotong and Liang, Ning and Sun, Jinyue and Liu, Chao and Ren, Qidong and Lu, Jihong and Hu, Pingping and Zhang, Jiandong},
  title = {Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03471-y}
}
Kostenlos starten →